Europe Age Related Macular Degeneration Drug Market Research Report Forecast 2017-2021

May 2017 | 121 pages | ID: EB4D871F6A6EN
S&P Consulting

Abstracts

The Europe Age Related Macular Degeneration Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Age Related Macular Degeneration Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Age Related Macular Degeneration Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Europe Age Related Macular Degeneration Drug Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Roche/Genentech
Novartis
Regeneron
Bayer
Valeant
Allergan
Alimera Sciences
Ophthotech
Acucela

Europe Age Related Macular Degeneration Drug Market Analysis by Product:

Type 1
Type 2
Type 3

Europe Age Related Macular Degeneration Drug Market Analysis by Application:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Europe Age Related Macular Degeneration Drug Sales Market Report Forecast 2017-2021

1 AGE RELATED MACULAR DEGENERATION DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Age Related Macular Degeneration Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Age Related Macular Degeneration Drug Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Age Related Macular Degeneration Drug (2012-2021)
  1.5.1 Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2021)
  1.5.2 Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON AGE RELATED MACULAR DEGENERATION DRUG INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

3.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE AGE RELATED MACULAR DEGENERATION DRUG MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Age Related Macular Degeneration Drug Market Competition by Manufacturers
  5.1.1 Europe Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Age Related Macular Degeneration Drug Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Age Related Macular Degeneration Drug (Volume and Value) by Type
  5.2.1 Europe Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
5.3 Europe Age Related Macular Degeneration Drug (Volume and Value) by Countries
  5.3.1 Europe Age Related Macular Degeneration Drug Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Age Related Macular Degeneration Drug Revenue and Market Share by Countries (2012-2017)
5.4 Europe Age Related Macular Degeneration Drug (Volume) by Application

6 GERMANY AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  6.1.1 Germany Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  6.1.2 Germany Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
6.2 Germany Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
6.3 Germany Age Related Macular Degeneration Drug Sales and Market Share by Type
6.4 Germany Age Related Macular Degeneration Drug Sales and Market Share by Application

7 FRANCE AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 France Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  7.1.1 France Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  7.1.2 France Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  7.1.3 France Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
7.2 France Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
7.3 France Age Related Macular Degeneration Drug Sales and Market Share by Type
7.4 France Age Related Macular Degeneration Drug Sales and Market Share by Application

8 UK AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 UK Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  8.1.1 UK Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  8.1.2 UK Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  8.1.3 UK Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
8.2 UK Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
8.3 UK Age Related Macular Degeneration Drug Sales and Market Share by Type
8.4 UK Age Related Macular Degeneration Drug Sales and Market Share by Application

9 RUSSIA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  9.1.1 Russia Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  9.1.2 Russia Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
9.2 Russia Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
9.3 Russia Age Related Macular Degeneration Drug Sales and Market Share by Type
9.4 Russia Age Related Macular Degeneration Drug Sales and Market Share by Application

10 ITALY AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  10.1.1 Italy Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  10.1.2 Italy Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
10.2 Italy Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
10.3 Italy Age Related Macular Degeneration Drug Sales and Market Share by Type
10.4 Italy Age Related Macular Degeneration Drug Sales and Market Share by Application

11 SPAIN AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  11.1.1 Spain Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  11.1.2 Spain Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
11.2 Spain Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
11.3 Spain Age Related Macular Degeneration Drug Sales and Market Share by Type
11.4 Spain Age Related Macular Degeneration Drug Sales and Market Share by Application

12 BENELUX AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  12.1.1 Benelux Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
12.2 Benelux Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
12.3 Benelux Age Related Macular Degeneration Drug Sales and Market Share by Type
12.4 Benelux Age Related Macular Degeneration Drug Sales and Market Share by Application

13 EUROPE AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURERS ANALYSIS

13.1 Roche/Genentech
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Novartis
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Regeneron
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Bayer
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Valeant
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Allergan
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Alimera Sciences
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Ophthotech
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Acucela
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE AGE RELATED MACULAR DEGENERATION DRUG MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Age Related Macular Degeneration Drug Market Forecast by Type (2017-2021)
15.9 Europe Age Related Macular Degeneration Drug Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure Europe Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015
Table Application of Age Related Macular Degeneration Drug
Figure Europe Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015
Figure Germany Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure France Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure UK Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Russia Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Italy Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Spain Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Benelux Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2021)
Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Table Europe Age Related Macular Degeneration Drug Sales of Key Manufacturers (2015 and 2016)
Table Europe Age Related Macular Degeneration Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Table Europe Age Related Macular Degeneration Drug Revenue by Manufacturers (2015 and 2016)
Table Europe Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 Europe Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table Europe Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Sales Growth Rate by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Revenue Growth Rate by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales and Market Share by Countries (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales Share by Countries (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Countries (2012-2017)
Table Europe Age Related Macular Degeneration Drug Revenue and Market Share by Countries (2012-2017)
Table Europe Age Related Macular Degeneration Drug Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Countries (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales and Market Share by Application (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Application (2012-2017)
Figure Germany Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Germany Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Germany Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Germany Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table Germany Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table Germany Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table Germany Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table Germany Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table Germany Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Figure France Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure France Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure France Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table France Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table France Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table France Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table France Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table France Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table France Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Figure UK Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure UK Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure UK Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table UK Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table UK Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table UK Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table UK Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table UK Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table UK Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Figure Russia Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Russia Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Russia Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Russia Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table Russia Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table Russia Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table Russia Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table Russia Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table Russia Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Figure Italy Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Italy Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Italy Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Italy Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table Italy Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table Italy Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table Italy Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table Italy Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table Italy Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Figure Spain Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Spain Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Spain Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Spain Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table Spain Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table Spain Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table Spain Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table Spain Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table Spain Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Figure Benelux Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Benelux Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Benelux Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Benelux Age Related Macular Degeneration Drug Sales by Manufacturers (2015 and 2016)
Table Benelux Age Related Macular Degeneration Drug Market Share by Manufacturers (2015 and 2016)
Table Benelux Age Related Macular Degeneration Drug Sales by Type (2015 and 2016)
Table Benelux Age Related Macular Degeneration Drug Market Share by Type (2015 and 2016)
Table Benelux Age Related Macular Degeneration Drug Sales by Application (2015 and 2016)
Table Benelux Age Related Macular Degeneration Drug Market Share by Application (2015 and 2016)
Table Roche/Genentech Basic Information List
Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche/Genentech Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Regeneron Basic Information List
Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Regeneron Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Valeant Basic Information List
Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Valeant Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alimera Sciences Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Ophthotech Basic Information List
Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Table Ophthotech Age Related Macular Degeneration Drug Sales Market Share (2012-2017)
Table Acucela Basic Information List
Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acucela Age Related Macular Degeneration Drug Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Germany Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure Germany Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Figure France Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure France Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Figure UK Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure UK Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure Russia Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure Italy Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure Spain Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Table Europe Age Related Macular Degeneration Drug Sales Forecast by Type (2017-2021)
Table Europe Age Related Macular Degeneration Drug Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Roche/Genentech, Novartis, Regeneron, Bayer, Valeant, Allergan, Alimera Sciences, Ophthotech, Acucela, Ohr Pharmaceuticals